M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Balance Sheet

Balance Sheet Decomposition
Middle East Pharmaceutical Industries Company SJSC

Current Assets 284.9m
Cash & Short-Term Investments 34.5m
Receivables 153.9m
Other Current Assets 96.5m
Non-Current Assets 170.9m
Long-Term Investments 1.1m
PP&E 122.1m
Intangibles 47.8m
Current Liabilities 116.7m
Accounts Payable 34.1m
Accrued Liabilities 24.1m
Short-Term Debt 40.9m
Other Current Liabilities 17.5m
Non-Current Liabilities 23.7m
Long-Term Debt 1.6m
Other Non-Current Liabilities 22.1m

Balance Sheet
Middle East Pharmaceutical Industries Company SJSC

Rotate your device to view
Balance Sheet
Currency: SAR
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
16
19
24
15
Cash
16
19
24
15
Total Receivables
113
167
157
165
Accounts Receivables
110
164
152
156
Other Receivables
3
3
6
10
Inventory
83
74
100
87
Other Current Assets
14
9
10
10
Total Current Assets
225
269
291
278
PP&E Net
95
103
106
119
PP&E Gross
95
103
106
119
Accumulated Depreciation
53
60
65
73
Intangible Assets
28
34
41
47
Long-Term Investments
23
10
4
1
Total Assets
371
N/A
417
+12%
442
+6%
445
+1%
Liabilities
Accounts Payable
26
33
38
28
Accrued Liabilities
10
8
10
17
Short-Term Debt
42
66
69
50
Current Portion of Long-Term Debt
0
5
6
6
Other Current Liabilities
6
6
8
12
Total Current Liabilities
85
117
132
113
Long-Term Debt
21
16
10
3
Minority Interest
0
0
0
0
Other Liabilities
13
17
21
22
Total Liabilities
118
N/A
150
+27%
162
+8%
138
-15%
Equity
Common Stock
60
60
200
200
Retained Earnings
192
207
80
106
Total Equity
252
N/A
267
+6%
280
+5%
306
+9%
Total Liabilities & Equity
371
N/A
417
+12%
442
+6%
445
+1%
Shares Outstanding
Common Shares Outstanding
20
20
20
20

See Also

Discover More